Medicare Enrolled
Dr. Jalal Damani, DO
Critical Care Medicine · Chicago, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Damani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Damani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Damani
Dr. Jalal Damani is a critical care medicine specialist in Chicago, IL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Damani performed 844 Medicare services across 660 unique beneficiaries.
Between the years covered by Open Payments, Dr. Damani received a total of $5,074 from 23 pharmaceutical and/or device companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in critical care medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Damani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 42% volume in IL
$5,074 industry payments
Medicare Practice Summary
Medicare Utilization ↗844
Medicare services
Top 42% in IL for critical care medicine
660
Unique beneficiaries
$107
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~77 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
137 | $99 | $229 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
105 | $176 | $616 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
90 | $142 | $394 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
76 | $99 | $278 |
| Bronchial secretion aspiration via endoscope Removal of initial lung airway secretions using an endoscope. This procedure involves inserting a scope into the airways to clear fluid or mucus. |
51 | $47 | $491 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
47 | $142 | $428 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
43 | $65 | $160 |
| Lung biopsy via endoscope, 1 lobe A procedure to remove a small sample of lung tissue from one lobe using an endoscope for examination. |
40 | $45 | $717 |
| Bronchoscopy with ultrasound and growth treatment A procedure using a flexible tube with a camera and ultrasound to examine the lung airways and treat any growths found. |
37 | $55 | $245 |
| Computer-assisted navigation of lung airways This procedure uses computer technology to guide an endoscope through the airways of the lungs for precise navigation. |
34 | $78 | $3,187 |
| Endoscopic needle biopsy of windpipe, airway, or lung A procedure where a needle is inserted through an endoscope to collect tissue samples from the windpipe, airway, or lung. |
34 | $130 | $1,089 |
| New patient office visit, complex (60-74 min) | 22 | $160 | $486 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
19 | $18 | $604 |
| Bronchoscopy with ultrasound and lymph node sampling A procedure using an endoscope and ultrasound to examine the lung airways and collect samples from 1 to 2 lymph nodes. |
19 | $102 | $1,500 |
| Chest fluid aspiration with imaging guidance This procedure involves removing fluid from the chest cavity using imaging technology to guide the needle placement. |
19 | $89 | $256 |
| Emergent tracheostomy An emergency procedure to create an opening in the windpipe to insert a breathing tube, guided by an endoscope. |
18 | $123 | $375 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
15 | $109 | $293 |
| Additional lung lobe biopsy via endoscope This procedure involves taking a tissue sample from an additional lobe of the lung using an endoscope, performed after an initial biopsy. |
14 | $41 | $241 |
| Thoracentesis, removal of fluid from between lung and chest cavity This procedure involves removing fluid that has accumulated in the space between the lung and the chest wall. |
12 | $114 | $696 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
12 | $122 | $371 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
19.3% medium
79.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$5,074
Total received (2018-2024)
Avg $725/year across 7 years
Top 25% in IL for critical care medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
118
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,074 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,424
2023
$1,147
2022
$1,516
2021
$862
2020
$57
2019
$20
2018
$49
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$764
GENZYME CORPORATION
$150
AstraZeneca Pharmaceuticals LP
$85
Regeneron Healthcare Solutions, Inc.
$65
Merck Sharp & Dohme LLC
$64
Electromed, Inc.
$60
GlaxoSmithKline, LLC.
$55
Insmed, Inc.
$42
Pinnacle Biologics, Inc
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$35
Philips North America LLC
$31
Pulmonx Corporation
$19
Bayer Healthcare Pharmaceuticals Inc.
$18
Top 3 companies account for 70.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$1,170
Pinnacle Biologics, Inc
$884
INTUITIVE SURGICAL, INC.
$764
GENZYME CORPORATION
$446
AstraZeneca Pharmaceuticals LP
$358
Regeneron Healthcare Solutions, Inc.
$276
Intuitive Surgical, Inc.
$155
GlaxoSmithKline, LLC.
$139
Olympus America Inc.
$110
Electromed, Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$94
Merck Sharp & Dohme LLC
$91
Inogen, Inc.
$80
Insmed, Inc.
$71
Pulmonx Corporation
$68
Genentech USA, Inc.
$61
Covis Pharma GmBH
$56
Baxter Healthcare
$36
Philips North America LLC
$31
Janssen Pharmaceuticals, Inc
$30
Mylan Specialty L.P.
$24
Bayer Healthcare Pharmaceuticals Inc.
$18
Lilly USA, LLC
$16
Top 3 companies account for 55.5% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AIRSUPRA · ALVESCO · Adempas · Arikayce · BREZTRI · CHARTIS CATHETER · CYRAMZA · DUPIXENT · Da Vinci Surgical System · FASENRA · GILOTRIF · Hillrom - Life 2000 Ventilation System · ILLUMISITE · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · InogenOne · NUCALA · OFEV · OPSUMIT · Photofrin · SMARTVEST · STIOLTO RESPIMAT · Spiration Valve System · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · Xolair · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Critical care medicines within 10 mi
189
Per 100K population
3.6
County median income
$81,797
Nearest hospital
SWEDISH HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Damani is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Damani experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Damani performed 137 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Damani receive payments from pharmaceutical companies?
Yes. Dr. Damani received a total of $5,074 from 23 companies across 118 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Damani's costs compare to other critical care medicines in Chicago?
Dr. Damani's average Medicare payment per service is $107. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Damani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Critical Care Medicines in Chicago
Browse critical care medicines in Chicago ranked by procedure volume and transparency data.
Highest volume
Top Critical Care Medicines in IL
Critical care medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Critical Care Medicines in IL
Which IL critical care medicines receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Pinnacle Biologics, Inc Payments to Doctors
See all physicians who received payments from Pinnacle Biologics, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology